GlassScriptPhysician profile
Lisa Pittarelli
NPI 1730155771
$2,792.14
in general payments reported to CMS, 2019-2025
18 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $494 · 2021: $272 · 2022: $300 · 2023: $302 · 2024: $466 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $704.12 | 2021-2025 | Apligraf, Affinity, Apligraf |
| Merck Sharp & Dohme LLC | $592.56 | 2019-2025 | Pifeltro, Dificid, Delstrigo |
| Gilead Sciences, INC. | $406.47 | 2019-2025 | |
| Smith+Nephew, INC. | $174.80 | 2019-2025 | Collagenase Santyl, Stravix Pl, Grafix Pl |
| Urgo Medical North America, LLC | $170.38 | 2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Paratek Pharmaceuticals, INC. | $136.66 | 2020-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $132.23 | 2019-2020 | |
| Shionogi INC | $83.18 | 2025 | Fetroja |
| Allergan, INC. | $72.19 | 2019-2020 | |
| Theratechnologies INC. | $65.14 | 2023-2024 | Trogarzo, Egrifta |
| Viiv Healthcare Company | $51.25 | 2019-2020 | |
| Abbvie INC. | $42.25 | 2023 | |
| Kerecis Limited | $37.01 | 2019 | |
| Emd Serono, INC. | $32.25 | 2021 | |
| Convatec INC. | $28.48 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24.30 | 2024 | |
| Apria Healthcare LLC | $23.68 | 2021 | |
| Integra Lifesciences Corporation | $15.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Pittarelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.